Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share News (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades64
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Company
Research
SYNC Company
Timeline
Syncona Information
Share Price Information for Syncona (SYNC)
Share Price is delayed by 15 minutes
Get Live Data
95.40
-0.80 (-0.83%)
Bid:
96.00
Ask:
96.80
Spread:
0.80 (0.833%)
Market Cap:
£580.22m
Last checked at -
Last checked at 
Intraday Syncona Share Chart
Syncona News
31 Mar 2020
Director dealings: Syncona chair acquires shares
(Sharecast News) - Syncona revealed on Tuesday that chairperson Melanie Gee had acquired 26,500 ordinary shares in the FTSE 250-listed life sciences i...
23 Mar 2020
Syncona flags delays to clinical programmes amid pandemic
(Sharecast News) - Syncona updated the market on its trading amid the Covid-19 coronavirus pandemic on Monday, reporting that since the start of the o...
23 Mar 2020
Syncona Expects Delays In Clinical Trials Due To Virus Disruption
Syncona Expects Delays In Clinical Trials Due To Virus Disruption
20 Mar 2020
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares
5 Mar 2020
DIRECTOR DEALINGS SUMMARY: IAG Chair And Director Spend EUR1.2 Million
DIRECTOR DEALINGS SUMMARY: IAG Chair And Director Spend EUR1.2 Million
24 Feb 2020
Monday broker round-up
(Sharecast News) - Rentokil: Jefferies upgrades to buy with a target price of 620p.
12 Feb 2020
Syncona Investee Presents Positive Data For Fabry, Gaucher Studies
Syncona Investee Presents Positive Data For Fabry, Gaucher Studies
7 Feb 2020
Syncona Investee Freeline Reports Positive Data From FLT180a Trial
Syncona Investee Freeline Reports Positive Data From FLT180a Trial
Follow the stocks
